...
首页> 外文期刊>Addictive disorders & their treatment >History of single episode and recurrent major depressive disorder among smokers in cessation treatment: Associations with depressive symptomatology and early cessation failure.
【24h】

History of single episode and recurrent major depressive disorder among smokers in cessation treatment: Associations with depressive symptomatology and early cessation failure.

机译:戒烟治疗中吸烟者的单发发作和复发性重度抑郁症的病史:与抑郁症状和早期戒断失败相关。

获取原文
获取原文并翻译 | 示例
           

摘要

OBJECTIVES: Research and theory provide initial support for the potential utility in distinguishing between recurrent and single episode MDD smokers for cessation treatment. However, no study to date has examined differences in clinical presentation at the outset of treatment among these two groups and whether these clinical profiles are indicative of early cessation failure (smoking on quit day). METHODS: In a secondary analysis of a sample of 179 smokers entering cessation treatment, we examined baseline differences in dysfunctional attitudes, maladaptive coping, self-efficacy to manage negative affect, depressive symptoms, depressed mood, and experienced pleasure from life events between smokers with a history of recurrent major depression (MDD-R; 54.7%) and single episode major depression (MDD-S). RESULTS: Results showed that MDD-R smokers reported lower self-efficacy to cope with negative affect, greater depressive symptoms, and greater depressed mood than MDD-S smokers, although no differences were found on dysfunctional attitudes, avoidance coping, and level of experienced pleasure from daily life events. A greater number of MDD-R compared to MDD-S smokers were not abstinent on their quit day, however a history of recurrent MDD did not increase risk for early cessation failure. CONCLUSIONS: The findings indicate that although depressed mood, negative affect-regulation ability, and depression severity distinguish recurrent and single episode MDD smokers at the start of cessation treatment, these differences do not necessarily portend greater risk for cessation failure in the early stages of treatment.
机译:目的:研究和理论为区分复发性和单发性MDD戒烟者的潜在效用提供了初步支持。但是,迄今为止,尚无研究检查两组在治疗开始时的临床表现差异,以及这些临床特征是否指示早期戒烟失败(戒烟日吸烟)。方法:在对接受戒烟治疗的179名吸烟者的样本进行的次要分析中,我们检查了基线差异,包括功能障碍,适应不良,应对自我效能的负面影响,抑郁症状,情绪低落以及吸烟者之间生活事件带来的愉悦感。复发性重度抑郁症(MDD-R; 54.7%)和单发性重度抑郁症(MDD-S)的病史。结果:结果表明,与MDD-S吸烟者相比,MDD-R吸烟者在应对负面影响,抑郁症状和情绪低落方面的自我效能较低,尽管在功能障碍态度,回避应对和经验水平方面没有差异日常生活中的乐趣。与戒烟当天不戒烟的MDD-R相比,戒烟的人数更多。但是,MDD复发的历史并没有增加戒烟失败的风险。结论:研究结果表明,尽管情绪低落,负面情绪调节能力和抑郁严重程度在戒烟治疗开始时就区分了复发性和单发MDD吸烟者,但这些差异并不一定预示着治疗初期戒烟失败的风险更大。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号